The fact that obestatin counteracts exaggerated β‐adrenergic activity, a relevant part of the neuroendocrine scenario in heart failure 63, and dilates coronary vessels in vitro (present study), as well as human vessels in vivo25, suggests that this peptide may exert multiple positive effects. The gene discussed is GHRL; the disease is heart failure.